Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
jeudi, octobre 01
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Minimed Group Inc
MMED
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$19.60
0.13
0.67%
Dern. MÀJ: Oct 1, 4:00 PM
$19.60
0.13
0.67%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Comparer
Options
Rapport sur les stocks
Privacy Manager
Minimed Group Analyst Price Targets - Benzinga
Minimed Group Analyst Price Targets
Wall Street analyst price targets and consensus rating for Minimed Group (MMED).
Analyst Ratings News
PRO
Truist Securities Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $29
Truist Securities analyst Richard Newitter initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating and announces Price Target of $29.
Benzinga Newsdesk
PRO
Morgan Stanley Maintains Overweight on Minimed Group, Raises Price Target to $21
Morgan Stanley analyst Kallum Titchmarsh maintains Minimed Group (NASDAQ:MMED) with a Overweight and raises the price target from $19 to $21.
Benzinga Newsdesk
PRO
Citigroup Maintains Buy on Minimed Group, Raises Price Target to $26
Citigroup analyst Joanne Wuensch maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price target from $23 to $26.
Benzinga Newsdesk
PRO
Evercore ISI Group Maintains Outperform on Minimed Group, Raises Price Target to $27
Evercore ISI Group analyst Daniel Markowitz maintains Minimed Group (NASDAQ:MMED) with a Outperform and raises the price target from $20 to $27.
Benzinga Newsdesk
PRO
Wells Fargo Maintains Overweight on Minimed Group, Raises Price Target to $26
Wells Fargo analyst Larry Biegelsen maintains Minimed Group (NASDAQ:MMED) with a Overweight and raises the price target from $22 to $26.
Benzinga Newsdesk
These Analysts Boost Their Forecasts On MiniMed Group Following Q1 Sales Results
MiniMed Group beat Q1 sales estimates with 16.6% growth to $843M; shares rose 7.1% as analysts raised price targets to $26-$28.
Avi Kapoor
Créez votre liste de surveillance
GRATUIT : Suivez les actions et les crypto-monnaies avec les meilleures notifications sur Internet
Cliquez ici pour commencer
People Also Watch
Alcon Inc
NYSE:ALC
$63.94
-1.25%
Medline Inc
NASDAQ:MDLN
$34.94
0.72%
Solventum Corp
NYSE:SOLV
$87.77
-0.44%
The Cooper Companies Inc
NASDAQ:COO
$57.41
1.57%
Align Technology Inc
NASDAQ:ALGN
$145.35
-%
Lantheus Holdings Inc
NASDAQ:LNTH
$99.65
-%
Bausch & Lomb Corp
NYSE:BLCO
$16.94
-%
Merit Medical Systems Inc
NASDAQ:MMSI
$86.15
-%
Haemonetics Corp
NYSE:HAE
$104.37
-%
ICU Medical Inc
NASDAQ:ICUI
$157.18
-2.16%
Afficher toutes les 10 entreprises associées
